Sodium–glucose cotransporter 2 inhibitors as an add-on therapy to insulin for type 1 diabetes mellitus: Meta-analysis of randomized controlled trials

AIMS: The aim was to systematically review the efficacy and safety of sodium–glucose cotransporter inhibitor (SGLT2i) as an adjunct to insulin at different follow-up durations in randomized, double-blind clinical trials in patients with type 1 diabetes. METHODS: We conducted a search on Medline, Emb...

Descripción completa

Detalles Bibliográficos
Autores principales: Rao, Lunwen, Ren, Chenhong, Luo, Shan, Huang, Chenghu, Li, Xuefeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8187227/
https://www.ncbi.nlm.nih.gov/pubmed/33651228
http://dx.doi.org/10.1007/s00592-021-01686-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8187227/
https://www.ncbi.nlm.nih.gov/pubmed/33651228
http://dx.doi.org/10.1007/s00592-021-01686-x

Ejemplares similares